The U.S. office-based labs market size was valued at USD 9.6 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.46% from 2022 to 2030. The primary factors influencing the market are the increasing number of surgical operations that are being conducted in outpatient settings and the high prevalence of vascular disorders in the U.S.
Vascular illnesses are becoming more common in the U.S. According to an AHA article from June 2021, 7% of individuals in the U.S. have peripheral arterial disease (PAD), which affects around 8.5 million people. Cardiovascular diseases are now more common than they were ten years ago, and this trend is predicted to accelerate exponentially. Over the past decade, the number of people with CVDs and PADs has increased by 13% in the United States. PADs often result in ischemic amputations and raise the risk of heart attack and stroke. This has driven the need for vascular surgical operations.
There are numerous service providers in the U.S., including National Cardiovascular Partners, Envision Healthcare, and Surgery Partners, who have been offering patients office-based surgical solutions and services at competitive prices. Prominent market players such as Philips Healthcare and Siemens Healthineers are collaborating with healthcare providers and medical professionals to set up OBLs, supplying laboratories with the necessary equipment, and offering end-to-end solutions.
The range of surgical treatments performed in office settings is expanding as a result of evolving reimbursement regulations for surgical operations. The Centers for Medicare and Medicaid Services expanded the types of surgical procedures that are covered when done in outpatient settings in 2021 and suggested new guidelines for operations that are reimbursed in ASCs.
Research Support Specialist, USA
FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...